Search
Stryker Corp
SYKAdd to Watchlist
302.105USD
+7.655+2.60%
Close 05/13, 16:00（ET）Quotes delayed by 15 min
115.83BMarket Cap
34.62P/E TTM
More Details of Stryker Corp Company
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Stryker Corp Info
Ticker SymbolSYK
Company nameStryker Corp
IPO dateMar 17, 1980
CEOLobo (Kevin A)
Number of employees53000
Security typeOrdinary Share
Fiscal year-endMar 17
Address1941 Stryker Way
CityPORTAGE
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code49002
Phone12693852600
Websitehttps://www.stryker.com/
Ticker SymbolSYK
IPO dateMar 17, 1980
CEOLobo (Kevin A)
Company Executives of Stryker Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
222.95K
+11.34%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
79.30K
+10.91%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
38.16K
-32.25%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.64%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
17.58K
+27.71%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
12.82K
+36.42%
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
6.47K
+1.44%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
5.91K
-3.45%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.87K
+1.58%
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
Independent Director
2.89K
+3.22%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
222.95K
+11.34%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
79.30K
+10.91%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
38.16K
-32.25%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.64%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
17.58K
+27.71%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
12.82K
+36.42%
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Medical
4.20B
16.74%
Trauma and Extremities
3.95B
15.72%
Endoscopy
3.81B
15.16%
Instruments
3.18B
12.67%
Knees
2.66B
10.57%
Other
7.32B
29.14%
By RegionUSD
Name
Revenue
Proportion
United States
19.01B
75.67%
Europe & Middle East & Africa (EMEA) (Region)
3.18B
12.67%
Asia Pacific (Region)
2.16B
8.62%
Other countries
765.00M
3.05%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Medical
4.20B
16.74%
Trauma and Extremities
3.95B
15.72%
Endoscopy
3.81B
15.16%
Instruments
3.18B
12.67%
Knees
2.66B
10.57%
Other
7.32B
29.14%
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
5.84%
Brown (John W)
5.23%
BlackRock Institutional Trust Company, N.A.
4.39%
Greenleaf Trust
4.16%
State Street Investment Management (US)
3.98%
Other
76.40%
Shareholders
Shareholders
Proportion
Vanguard Capital Management, LLC
5.84%
Brown (John W)
5.23%
BlackRock Institutional Trust Company, N.A.
4.39%
Greenleaf Trust
4.16%
State Street Investment Management (US)
3.98%
Other
76.40%
Shareholder Types
Shareholders
Proportion
Investment Advisor
45.14%
Investment Advisor/Hedge Fund
21.50%
Bank and Trust
6.47%
Individual Investor
5.39%
Research Firm
3.39%
Pension Fund
2.17%
Hedge Fund
1.44%
Sovereign Wealth Fund
1.40%
Family Office
0.13%
Other
12.99%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
3695
312.34M
81.56%
-3.59M
2025Q4
3571
314.41M
82.22%
-3.81M
2025Q3
3494
311.59M
81.48%
-5.78M
2025Q2
3464
329.22M
86.11%
-1.59M
2025Q1
3477
331.34M
86.70%
+478.07K
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Brown (John W)
20.06M
5.24%
--
--
Feb 28, 2026
BlackRock Institutional Trust Company, N.A.
16.84M
4.4%
+573.61K
+3.53%
Dec 31, 2025
Greenleaf Trust
15.31M
4%
-1.25M
-7.55%
Feb 28, 2026
State Street Investment Management (US)
15.25M
3.98%
+311.51K
+2.08%
Dec 31, 2025
T. Rowe Price Associates, Inc.
9.61M
2.51%
-872.48K
-8.33%
Dec 31, 2025
JP Morgan Asset Management
8.00M
2.09%
+868.19K
+12.17%
Dec 31, 2025
Geode Capital Management, L.L.C.
7.54M
1.97%
+69.85K
+0.94%
Dec 31, 2025
Wellington Management Company, LLP
6.49M
1.7%
+1.20M
+22.64%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Jensen Quality Growth ETF
6.01%
iShares U.S. Medical Devices ETF
4.17%
AdvisorShares Focused Equity ETF
3.62%
Gabelli Growth Innovators ETF
3%
Global X Aging Population ETF
2.85%
Hennessy Sustainable ETF
2.77%
Knowledge Leaders Developed World ETF
2.73%
Health Care Select Sector SPDR Fund
2.51%
Proshares Ultra Health Care
2.42%
iShares U.S. Healthcare ETF
2.4%
View more
Jensen Quality Growth ETF
Proportion6.01%
iShares U.S. Medical Devices ETF
Proportion4.17%
AdvisorShares Focused Equity ETF
Proportion3.62%
Gabelli Growth Innovators ETF
Proportion3%
Global X Aging Population ETF
Proportion2.85%
Hennessy Sustainable ETF
Proportion2.77%
Knowledge Leaders Developed World ETF
Proportion2.73%
Health Care Select Sector SPDR Fund
Proportion2.51%
Proshares Ultra Health Care
Proportion2.42%
iShares U.S. Healthcare ETF
Proportion2.4%
Dividend
A total of
4.36B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
May 07, 2026
SYK.NB Interim Cash Dividend of gross USD 0.88 paid on Jul 31, 2026 going ex on Jun 30, 2026
Jun 30, 2026
Jul 31, 2026
Jun 30, 2026
Feb 04, 2026
SYK.NB Interim Cash Dividend of gross USD 0.88 paid on Apr 30, 2026 going ex on Mar 31, 2026
Mar 31, 2026
Apr 30, 2026
Mar 31, 2026
Dec 11, 2025
SYK.NB Final Cash Dividend of gross USD 0.88 paid on Jan 30, 2026 going ex on Dec 31, 2025
Dec 31, 2025
Jan 30, 2026
Dec 31, 2025
Aug 07, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Oct 31, 2025 going ex on Sep 30, 2025
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 08, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Jul 31, 2025 going ex on Jun 30, 2025
Jun 30, 2025
Jul 31, 2025
Jun 30, 2025
Feb 05, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
View more
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
